RESULTS Both DDP and VP16 obviously inhibited the lung cancer cell growth with dose and time dependent.
结果不同浓度VP16和DDP对肺癌细胞生长均有明显的抑制作用，并有浓度和时间的依赖性。
A549 lung cancer cell was cultivated by the magnetized water, and the growth curve was drawn by MTT colorimetry.
然后将磁化水应用于A549肺癌细胞的体外培养，观察a 549肺癌细胞的生长情况，用MTT比色法绘制细胞生长曲线。
To investigate the fraction of cancer initiating cells in lung cancer cell line A549 by cloning and tumorigenic analyses.
目的通过克隆形成及致瘤能力研究肺腺癌细胞系a549肿瘤始发细胞的比例。
Objective to investigate the regulatory effects of tuberculin on growth and apoptosis of liver cancer and lung cancer cell lines.
目的探讨结核菌素对肝癌和肺癌肿瘤细胞生长和凋亡的调控作用。
Objective To establish a successful xenotransplantation model of a human small cell lung cancer cell line (NCI_H446) in nude mice.
目的建立成瘤稳定、潜伏期短的人小细胞肺癌nci_h4 4 6细胞裸鼠移植瘤模型。
This study is intended to investigate the anticancer effects of the low toxic flavorings cinnamic acid on PGCL3 human lung cancer cell subine.
本研究的目的是探讨低毒性的食品调味剂桂皮酸对PGCL3人肺癌细胞的抑制作用。
Objective: To study the effects on proliferation inhibition and anti-invasion of glycyrrhizin in highly metastasis lung cancer cell line (PGCL3).
目的：探讨甘草酸对高转移人肺癌细胞(PGCL3)增殖抑制和抗侵袭的作用。
These compounds were assayed for inhibitory activity against A549 lung cancer cell growth, and the inhibitory effects on the cell viability were dose-dependent.
所得化合物均具有抑制A549肺癌细胞生长的活性，其抑制效果具有浓度依赖性。
Conclusion the petroleum ether extracts of Anthriscus have obvious inhibitory effect on the proliferation of lung cancer cell, which can induce the cells' apoptosis.
结论峨参石油醚提取物对肺癌细胞增殖具有明显的抑制及诱导凋亡的作用。
Objective To explore the relationship of chemotherapy sensitivity and expression of multidrug resistance genes and apoptosis regulation genes in human lung cancer cell lines.
目的探讨人肺癌细胞株对化疗药物的敏感性与多药耐药相关基因和凋亡调控基因表达的关系。
The TNM system may be applied to small-cell lung cancer (SCLC), but management decisions are not as closely guided by it.
同时，TNM系统也可用于小细胞癌（SCLC），但并非以此作为治疗指南。
Non-small-cell lung cancer grows more slowly and is more common, accounting for almost 90% of all lung cancers.
另外一种非小细胞癌，生长更慢些，也更为常见，90%的肺癌都是这种类型。
The cancer concerned, known rather cryptically as non-small-cell lung cancer, is actually the most common form of the disease, accounting for about 80% of cases.
而Bang研究的肺癌种类是并不是某些罕见的如非小细胞肺癌之类，而是最常见的种类，约80%的病例都是罹患这种肺癌。
One in five lung cancer sufferers have a particularly virulent strain called small cell lung cancer which kills all but three per cent of sufferers within five years of diagnoses.
1/5的癌症患者带有一种特别的有毒病株，称为小细胞肺癌，这种肺癌五年内杀死了近3%的确诊患者。
Small-cell lung cancer is divided into two stages: "Limited" means the cancer is confined to one lung and maybe nearby lymph nodes.
小细胞癌分为2期：局限性，肺癌局限一个肺中，可能邻近的淋巴结会有癌细胞；
Surgery is usually not an option for patients with small-cell lung cancer because it typically has already spread at the time of diagnosis.
对于小细胞肺癌的患者，手术通常并不是最好的选择，因为往往在诊断的时候就已经扩散了。
There are two major types: non-small cell lung cancer, which is the most common, and small cell lung cancer, which spreads more quickly.
有两种主要类型：最常见的是“非小细胞肺癌”；另一种是扩展非常迅速的“小细胞肺癌”。
The information was collected from people 65 and older who died from non-small-cell lung cancer between 1999 and 2003.
这些信息是从1999 - 2003年里65岁及以上因患非小细胞肺癌死亡的患者那里收集到的。
The TNM lung cancer staging system is primarily utilized for non-small-cell lung cancer (NSCLC), which accounts for approximately 75% of lung cancer diagnoses.
肺癌的TNM系统最初用于非小细胞癌(NSCLC)，这种癌大约占所有肺癌的75%。
Prof Seckl said: "I have been working on small cell lung cancer for many years and to find something that can take a measurable piece of tumour and make it go away is wonderful.
塞克尔教授说：“我研究小细胞肺癌多年，发现能够消除大块肿瘤并使之消失是件美妙的事。”
Small-cell lung cancer is the more aggressive of the two, meaning it can spread quickly to other parts of the body early in the disease.
一种是小细胞肺癌，这种肺癌更具侵袭性，在早期就能扩散到其他器官。
Pfizer’s crizotinib attacks a protein encoded by a gene found in fewer than 5% of patients with non-small-cell lung cancer.
辉瑞公司的crizotinib攻击某种蛋白质，这种蛋白质由在不到5%的非小细胞肺癌患者中发现的一种基因编码。
Objective to investigate the expression of COX-2 and its relation to clinical pathophysiological features and prognosis in non-small cell lung cancer (NSCLC).
目的探讨非小细胞肺癌组织中COX 2的表达情况及其与患者临床病理生理特征和预后的关系。
Medical oncologists are faced with multiple factors to consider when staging a patient with suspected or confirmed non-small cell lung cancer (NSCLC).
肿瘤病学家在对可疑或确诊的非小细胞肺癌患者进行分期时要面临多方面因素的考量。
PURPOSE: To determine the epidemiology, pathology and patterns of care for patients with non-small cell lung cancer (NSCLC) in the United States.
目的：为了测定美国非小细胞肺癌患者的流行病学、病理学和治疗模式。
Background and objective Chemotherapy is very important in the treatment of advanced non-small cell lung cancer.
背景与目的化疗在晚期非小细胞肺癌的治疗中具有极为重要的作用。
Bevacizumab is also not used in cases of squamous cell cancer, because it leads to bleeding from this type of lung cancer.
贝伐单抗，也是没有用的情况下鳞状细胞癌，因为它会导致出血，从这种类型的肺癌。
Chemotherapy given in combination with ligands for the peroxisome proliferator-activated receptor - (PPAR) synergistically inhibits the growth of lung and ovarian cancer cell lines.
化疗药物联合过氧化物酶体增殖物激活受体(PPAR)的配体能够协同抑制肺细胞癌及卵巢癌细胞。
Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.
中国的非小细胞肺癌病人中吉非替尼敏感的表皮生长因子受体酪氨酸激酶区域的突变。
Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.
中国的非小细胞肺癌病人中吉非替尼敏感的表皮生长因子受体酪氨酸激酶区域的突变。
应用推荐